Clinical Trial Update: Role of Vitamin C to Augment Iron Chelation With DFP or DFX [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes Phase 2 and Phase 3 studies evaluating whether vitamin C can augment iron chelation with deferiprone or deferasirox in pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thalassemia Major

Drugs mentioned

• Exjade (deferasirox) (deferasirox)
• Ferriprox (deferiprone) (deferiprone)
• Jadenu (deferasirox) (deferasirox)
• Vitamin C (ascorbic acid) (ascorbic acid)

Snippet

Sponsor: Ain Shams University | Conditions: Vitamin c, Thalassemia Major | Phase 2, Phase 3 | Status: UNKNOWN